Clinical

Dataset Information

0

Investigation of the tumor concentrations of the anticancer drug osimertinib in tumor resection material of patients with colorectal cancer.


ABSTRACT: Primary objectives: To determine the intratumoral concentration of osimertinib in peritoneal metastasis upon 2 weeks of treatment of patients who are candidate for CRS-HIPEC treatment (group 1), and in liver metastasis of patients who are candidate for primary liver resection (group 2). These clinical determined intratumoral osimertinib concentrations will be compared with the effective tissue concentrations in PDTOs from PM of CRC from the PDO-CRPM study. Primary endpoints: Intratumoral osimertinib concentration in peritoneal metastasis and liver metastasis.

DISEASE(S): Colorectal Cancer

PROVIDER: 26958 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

2020-03-24 | GSE124878 | GEO
2022-10-01 | GSE198085 | GEO
2006-04-14 | GSE4668 | GEO
2023-06-30 | GSE235526 | GEO
2009-11-10 | GSE17968 | GEO
2020-12-13 | GSE156188 | GEO
2010-05-28 | E-GEOD-18255 | biostudies-arrayexpress
2020-04-17 | PXD015059 | Pride
| PRJNA125073 | ENA
2024-11-25 | GSE282440 | GEO